Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Cardiovascular Risk II (MoKaRi II) Intervention Study - Modulation of Cardiovascular Risk and Diabetes Risk Using Menu Plans

NCT05382533 is registered in ClinicalTrials.gov with University of Jena as lead sponsor.

NCT NCT05382533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Cardiovascular Risk II (MoKaRi II) Intervention Study - Modulation of Cardiovascular Risk and Diabetes Risk Using Menu Plans
Lead sponsor
University of Jena
Phase
Not applicable
Overall status
Completed
Start date
May 30, 2022
Completion date
December 14, 2022
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decreased cardovascular risk, decreased risk of diabetes mellitus type ii